Microduplication Xp11.22-p11.23 syndrome
Alternate names
Chromosome Xp11.23-p11.22 duplication syndrome ; Trisomy Xp11.22-p11.23; Dup(X)(p11.22p11.23); Microduplication Xp11.22p11.23 syndrome; Trisomy Xp11.22p11.23
Definition
Familial and de novo recurrent Xp11.22-p11.23 microduplication has been recently identified in males and females.
Epidemiology
To date, twelve patients have been described.
Cause
- The microduplication was identified by microarray-based comparative genomic hybridization (aCGH).
- Most affected females show preferential activation of the duplicated X chromosome.
- Duplications are mediated by nonallelic homologous recombination (NAHR) or Alu-mediated recombination.
Signs and symptoms
- All patients show moderate to severe intellectual deficit and speech delay.
- Seizures, early puberty and lower-extremity anomalies, including pes planus or cavus, 5th toe hypoplasia, and syndactyly, are common.
- A peculiar electroencephalographic (EEG) pattern characterized by rolandic-like spikes and/or continuous spike wave during slow sleep (CSWS) exists in childhood.
Clinical presentation
For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed.
80%-99% of people have these symptoms
- Delayed speech and language development(Deficiency of speech development)
- Intellectual disability(Mental deficiency)
30%-79% of people have these symptoms
- EEG with centrotemporal focal spike waves
- Hoarse voice(Hoarseness)
- Nasal speech(Nasal voice)
- Obesity(Having too much body fat)
- Pes cavus(High-arched foot)
- Pes planus(Flat feet)
- Precocious puberty(Early onset of puberty)
- Seizure
- Toe syndactyly(Fused toes)
5%-29% of people have these symptoms
Diagnosis
Treatment
NIH genetic and rare disease info
Microduplication Xp11.22-p11.23 syndrome is a rare disease.
Resources
Frequently asked questions
Additional resources | |
|---|---|
Microduplication Xp11.22-p11.23 syndrome | |
| About WikiMD |  |
 | This Microduplication Xp11.22-p11.23 syndrome article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju
